Highly Selective PPARα (Peroxisome Proliferator‐Activated Receptor α) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular‐Microstructural Imaging
Hiroshi Iwata(Brigham and Women's Hospital), Farouc A. Jaffer(Harvard University)
Cited by 14
Related Papers
PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
|Nature Communications|2016|306